Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjogren's syndrome

被引:29
作者
Kohriyama, K [1 ]
Katayama, Y [1 ]
机构
[1] Kobe W City Hosp, Dept Internal Med, Nagata Ku, Kobe City, Hyogo 6530013, Japan
关键词
Th1 and Th2 cells; Cd4+cells; cytoplasmic INF-gamma; cytoplasmic IL-4; primary Sjogren's syndrome;
D O I
10.3109/08916930008995989
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the proportions of Th1 and Th2 cells in peripheral blood of 15 patients with primary Sjogren's syndrome( p-SS), by using a procedure to enumerate the cells synthesizing cytokines such as INF-gamma or IL-4 in cytoplasm of CD4+ lymphocytes, The frequency of Th1 (INF-gamma containing) cells in p-SS patients was significantly reduced as compared to normal control (20.57+/-7.48% vs 28.78 +/- 11.56%, p < 0.05), while that of Th2 (1L-4 containing) cells was not different from normal control (3.33 +/- 0.98% vs 2.85 +/- 1.88%), The ratio of Th1 to Th2 cells in p-SS patients was significantly decreased as compared to normal control (6.60 +/- 3.15 vs 11.55 +/- 6.72, p < 0.05), There was no difference in frequency of Th1 or of Th2 cells between 8 patients given small amounts of prednisolone (PSL) and 7 patients not given PSL (21.44+/-9.39% vs 19.57+/-5.05%, 3.12+/-0.80% vs 3.56+/- 1.17%), The percentage of Th1 cells was not different between 7 patients with glandular symptoms (G) and 8 patients with extraglandular symptoms (EG) (18.61+/-9.63% vs 22.27+/-5.02%). Although the frequency of Th2 cells was higher in EG-patients than that in G-patients (3.84 +/- 0.78% vs 2.74 +/- 0.86%) with tendency of elevated IgG level in sera, the ratio of Th1 to Th2 cells was not different among them (6.26 +/- 2.84 vs 6.99 +/- 3.64), These results suggest that the reduced ratio of Thl to Th2 cells is essential and is related to the dysfunction of cellular immunity in p-SS.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 16 条
  • [1] BOUMBA D, 1995, BRIT J RHEUMATOL, V34, P326
  • [2] CYTOKINES IN AUTOIMMUNITY
    BRENNAN, FM
    FELDMANN, M
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (06) : 754 - 759
  • [3] CAVALLO MG, 1994, CLIN EXP IMMUNOL, V96, P1
  • [4] FOX RI, 1994, J IMMUNOL, V152, P5532
  • [5] Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219
  • [6] Increased production of B cell growth factor (BCGF) in Sjogren's syndrome
    Goto, Y
    Itoh, M
    Ogawa, N
    Goto, Y
    Ohashi, H
    Ohno, R
    [J]. JOURNAL OF AUTOIMMUNITY, 1996, 9 (04) : 545 - 550
  • [7] Hagiwara E, 1998, J RHEUMATOL, V25, P89
  • [8] Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO
  • [9] 2-S
  • [10] DECREASED AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN SJOGRENS SYNDROME
    MIYASAKA, N
    SAUVEZIE, B
    PIERCE, DA
    DANIELS, TE
    TALAL, N
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (05) : 928 - 933